2024-10-26 20:27:07
Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022
Corporate/ 2023-07-24
Innovent and Eli Lilly and Company Annou...

SAN FRANCISCO and SUZHOU,China,Jan. 22,2022-- Innovent Biologics,Inc. ("Innovent",HKEX: 01801),a world-class biopharmaceutical com...

Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma
Corporate/ 2023-07-24
Ascletis Announces First Patient Dosed i...

HANGZHOU and SHAOXING,China,Jan. 23,2022-- Ascletis Pharma Inc. (HKEX code: 1672) today announces the dosing of the first patient in the Pha...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release